The latest closing stock price for Lucid Diagnostics as of September 18, 2024 is 0.83.
An investor who bought $1,000 worth of Lucid Diagnostics stock at the IPO in 2021 would have $-929 today, roughly -1 times their original investment - a -58.64% compound annual growth rate over 3 years.
The all-time high Lucid Diagnostics stock closing price was 11.76 on October 14, 2021.
The Lucid Diagnostics 52-week high stock price is 1.58, which is 90.4% above the current share price.
The Lucid Diagnostics 52-week low stock price is 0.63, which is 24.1% below the current share price.
The average Lucid Diagnostics stock price for the last 52 weeks is 1.08.
An investor who bought $1,000 worth of Lucid Diagnostics stock at the IPO in 2021 would have $-929 today, roughly -1 times their original investment - a -58.64% compound annual growth rate over 3 years.
The all-time high Lucid Diagnostics stock closing price was 11.76 on October 14, 2021.
The Lucid Diagnostics 52-week high stock price is 1.58, which is 90.4% above the current share price.
The Lucid Diagnostics 52-week low stock price is 0.63, which is 24.1% below the current share price.
The average Lucid Diagnostics stock price for the last 52 weeks is 1.08.